EXPANSION ADDS STATE-OF-THE-ART UPSTREAM AND DOWNSTREAM GMP PROCESSING CAPABILITIES TO MEET THE GROWING DEMAND FOR 2,000 ...

Bora Biologics just gave San Diego's biotech scene a serious flex, cutting the ribbon on a $30 million expansion of its FDA-registered manufacturing campus in Sorrento Valley. The upgrade adds ...

SHANGHAI, Nov. 22, 2023 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced today that it has ...

For decades, therapeutic monoclonal antibody (mAb) production relied on traditional batch-based manufacturing using stainless steel systems. But as biopharmaceutical pipelines grow to meet rising ...

Extracting therapeutic antibodies from biological systems requires stringent purification processes. To reduce costs and accelerate development, novel strategies are essential ...

SHANGHAI, Aug. 30, 2024 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today announced that it has ...

The demands of developing new biologic modalities like bispecific antibodies are pushing the limits of traditional drug manufacturing. For the modern biomanufacturer, process intensification is ...

The market is poised for growth (12.88% CAGR), driven by high demand for equipment due to capacity expansions, and the adoption of single-use systems, continuous bioprocessing, and digital twinsDublin ...

Continuous bioprocessing has emerged as a transformative approach in modern biomanufacturing, where integrated upstream and downstream operations enable uninterrupted production of biotherapeutics.

Continuous bioprocessing has emerged as a transformative approach in modern biomanufacturing, where integrated upstream and downstream operations enable uninterrupted production of biotherapeutics.

Non-specific Endonuclease Market to reach US$ 726.6 Bn by 2036 at 6.5% CAGR, driven by rising biotechnology research, ...